Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
T863 has been used as a diglyceride acyltransferase (DGAT1) inhibitor:to provide the opportunity to precisely control the DGAT inhibitionto treat mouse embryonic fibroblasts (MEFs) to analyse lipid droplet biogenesisto specifically block neutrallipid synthesisand lipid droplet formation in HT-1080 cellsto block lipid droplet (LD) formation
Biochem/physiol Actions
T863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells. T863 causes weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity in obese mice.
Packaging
5, 25 mg in glass bottle
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :